Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2009;40:S2-S3
Published online before print December 8, 2008, doi: 10.1161/STROKEAHA.108.534404
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
40/3_suppl_1/S2    most recent
STROKEAHA.108.534404v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lo, E. H.
Right arrow Articles by Rosenberg, G. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lo, E. H.
Right arrow Articles by Rosenberg, G. A.
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Degenerative Nerve Diseases
*Stroke
Related Collections
Right arrow Other Stroke Treatment - Medical

(Stroke. 2009;40:S2.)
© 2009 American Heart Association, Inc.


Neurovascular Unit

The Neurovascular Unit in Health and Disease

Introduction

Eng H. Lo, PhD Gary A. Rosenberg, MD

From the Departments of Radiology and Neurology (E.H.L.), Massachusetts General Hospital and Harvard Medical School, Boston, Mass; and Departments of Neurology, Neurosciences, and Cell Biology, and Physiology (G.A.R.), University of New Mexico Health Sciences Center, Albuquerque, NM.

Correspondence to Gary A. Rosenberg, MD, Department of Neurology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131. E-mail grosenberg@salud.unm.edu


Key Words: cerebrovascular disease • astrocytes • blood–brain barrier • vascular cognitive impairment • Huntingtin • pericytes


An extract of the first 250 words of the full text is provided, because this article has no abstract.
 

Over the past 10 years, study of the blood vessel in cerebrovascular disease has expanded from consideration of only endothelial cells to include interactions with neurons, astrocytes, pericytes, and extracellular matrix. The role of other cells in the pathobiology of cerebral blood vessels has been encompassed under the term "neurovascular unit (NVU)." This session brings together a series of papers on the role of the NVU in stroke and neurodegenerative diseases. The endothelial cell remains central to the NVU, but its function is regulated by input from adjacent pericytes, astrocytes, and neurons.1 The extracellular matrix and the matrix-degrading enzymes and inhibitors play a key role at the basal lamina and the cell surface in the regulation of cell signaling.2 Much has been learned about the function of astrocytes, which rapidly transduce information between the microenvironment and other brain cells and the macrophage-like pericytes in effecting changes at the cerebral capillary level. The presentations were arranged to emphasize recent advances in our understanding of the anatomy and physiology of the NVU (Lo), recent studies on the astrocytes (Nedergaard), and pericytes (Fisher). The final 2 presentations describe the role of extracellular matrix enzymes in amyloid metabolism as it relates to Alzheimer disease (Lee) and vascular cognitive impairment (Rosenberg). The goal of the session was to provide an overview on the role of the separate cell types composing the NVU and to show how they interact in acute and chronic cerebrovascular diseases.

Transgenic mice have been used to explore the role of individual . . . [Full Text of this Article]